Status:
COMPLETED
Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Nova Biomedical Corporation
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study is being done to see if the Nova Creatinine Meter can give a correct measure of creatinine (a blood test used to measure kidney function) when the blood is taken from a capillary (smallest ...
Eligibility Criteria
Inclusion
- Written Informed Consent
- Must have a creatinine \> or = to than 3.5 mg/dl
Exclusion
- Patients who are less than 18 years of age
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00607529
Start Date
August 1 2007
End Date
May 1 2010
Last Update
June 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065